期刊文献+

结核分支杆菌耐喹诺酮分子机制的研究 被引量:3

Studies of molecular mechanism of quinolone-resistant in Mycobacterium tuberculosis isolates
下载PDF
导出
摘要 目的了解结核分支杆菌耐喹诺酮药物的分子机制,建立快速的药敏的方法。方法通过16SrRNA聚合酶链反应-单链构象多态性(PCR-SSCP)技术分析77株分支杆菌临床分离株;通过PCR-SSCP和直接测序技术(PCR-DS)分析结核分支杆菌的gyrA基因突变的情况。结果75株为结核分支杆菌复合群。以结核分支杆菌标准菌株H37Rv和卡介苗为对照,30株喹诺酮敏感株的gyrA基因的SSCP图谱均泳动正常,测序分析与对照株相同。45株耐喹诺酮的菌株中,34株(75.6%)gyrA基因SSCP图谱泳动异常;测序证实10株为90位密码子的突变,24株为94位密码子突变,所有gyrA突变株的氧氟沙星4μg/ml≤MICs≤32μg/ml,左氧氟沙星2μg/ml≤MICs≤16μg/ml。结论gyrA基因突变,尤其90位和94位密码子突变是结核分支杆菌耐喹诺酮的主要分子机制,PCR-SSCP可能成为测定部分结核分支杆菌喹诺酮耐药基因型的简便、快速的方法,并有望直接用于临床标本喹诺酮敏感性试验。 Objective To study the molecular mechanism in M.tuberculosis quinolones-resistant ~isolates , and develop a new method for detection of drug resistance. Methods Seventy-seven clinical isolates were identified for their mycobacteria species, and the gyrA genes mutation of M.tuberculosis were analyzed with PCR-SSCP and PCR-direct sequencing. Results Seventy-five isolates were identified as M.tuberculosis. The standard strain of M.tuberculosis H37Rv and BCG as control were used. All of 30 quinolones-sensitive ~isolates had the same gyrA SSCP profiles as the controls. Among 45 quinolones-resistant isolates, 34(75.6%) displayed abnormal gyrA SSCP profiles; DNA direct sequencing of gyrA gene was performed, the mutation at codon 90 of gyrA occurred in 10 quinolones-resistant isolates; the mutation at codon 94 of gyrA occurred in 24 quinolones-resistant isolates, the MICs of ofloxacin were higher than 4μg/ml and lower than 32 μg/ml, while the MICs of levofloxacin were higher than 2μg/ml and lower than 16μg/ml in all mutational isolates. Conclusion Quinolones resistances in some M.tuberculosis isolates were due to mutation on gyrA genes, especially the mutations at 90 and 95 codons. PCR-SSCP method might become a simple and rapid diagnostic test for genotypes of M.tuberculosis quinolones-resistance.
机构地区 解放军
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第2期103-106,共4页 Chinese Journal of Antibiotics
关键词 结核分支杆菌 喹诺酮 GYRA基因 药物耐受性 聚合酶链反应 单链构象多态性 DNA直接测序 Mycobacterium tuberculosis Quinolones gyrA gene Drug resistance Polymerase chain reaction Single-stranded conformation polymorphism DNA sequencing
  • 相关文献

参考文献14

  • 1吴雪琼,张俊仙,刘佳文,黄海南,王晋洪.PCR-SSCP分支杆菌菌种初步鉴定方法的建立及其应用[J].中国现代医学杂志,2000,10(7):25-26. 被引量:46
  • 2Jarlier V, Nikaido H. Permeability barrier to hydrophilic solutes in Mycobacterium chelonei [J ]. J Bacteriol, 1990,172:1418.
  • 3Takiff H E, Cimino M, Musso M C. et al. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis [J].Proc Natl Acad Sci USA. 1996.93 : 362.
  • 4Yew W W. Chan C K, Leang C C. et al. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong [J]. Chest, 2003,124(4): 1476.
  • 5Alangaden G J, Lerner S A. The clinical use of flouroquinolones for the treatment of Mycobacterial diseases[J]. Clin Infect Dis, 19 9 7 , 2 5 : 1213.
  • 6Richeldi L, Covi I. Ferrara G, et al. Clinical use of levofloxacin in the long-term treatment of drug resistant tuberculosis [J]. Monaldi Arch Chest Dis, 2002,57 ( 1 ) : 39.
  • 7Takiff H E, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations [J]. Antimicrob Agents Chemother, 1994, 38(4):773.
  • 8Alangaden G J, Manavathu E K, Vakulenko S B, et al.Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients [J]. Antimicrob Agents Chemother, 1995,39 (8) : 1700.
  • 9Guillemin I, Cambau E, Jarlier V. Sequences of conserved region in the a subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis an dimplication for intrinsic susceptibility to quinolones [J].Antimicrob Agents Chemother , 1995,39 (9):2145.
  • 10Kocagoz T, Hackbarth C J, Unsal I, et al. Gyrase mutations in laboratory-selected, fluoroquinolone- resistance,mutants of Mycobacterium tuberculosis H37Ra [J ].Antimicrob Agents Chemother , 1996,40(8) : 1768.

二级参考文献1

共引文献45

同被引文献53

  • 1安慧茹,王巍,王天昊,何珂,刘真,李素梅.结核分支杆菌喹诺酮耐药基因的研究[J].医学临床研究,2005,22(1):23-25. 被引量:4
  • 2姜平,王国扬,冯柏,王巍,李洪敏,张芳.煤工尘肺结核耐喹诺酮类分离株gyrA基因突变的研究[J].中华劳动卫生职业病杂志,2006,24(2):124-125. 被引量:3
  • 3李洪敏,姜平,王巍,王国洋,吴雪琼,冯柏,安慧茹.矽肺结核病耐喹诺酮(gyrA)基因情况分析[J].传染病信息,2006,19(1):28-29. 被引量:3
  • 4中国防痨协会基础委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.
  • 5Aziz M A, Wright A, Laszlo A, et al. Epidemiology of antitu berculosis drug resistance (the Global Project on Anti-Tuberculo sis Drug Resistance Surveillance) : an updated analysis[J]. Lancet, 2006, 368(9553), 2142-2154.
  • 6中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007—2008年)[R].北京:人民卫生出版社.2010.
  • 7Aubry A X, Pan S, Fisher L M, et al. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity[J]. Antimicrob Agents Chemother. 2004,48(4):1281-1288.
  • 8Dauendorffer JN, Guillemin I, Aubry A, et al. Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes[J]. J Clin Microbiol. 2003, 41(3) :1311-5.
  • 9World Health Organization. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs[S]. World Health Organization, Geneva, Switzerland, 2008.
  • 10van Embden J D, Cave M D, Crawford J T, et al. Strain identifi cation of Mycobacterium tuberculosis by DNA fingerprinting recommendations for a standardized methodology[J].J Clin Microbiol, 1993, 31 (2): 406-409.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部